19 results
8-K
EX-10.2
INM
InMed Pharmaceuticals Inc
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
the plural, and vice versa, the use of any term is generally applicable to either gender and, where applicable, to a corporation, the word
DEF 14A
kdwbyxk6
28 Oct 21
Definitive proxy
3:07pm
S-8
EX-4.2
tnwos81 u7kq39
5 Mar 21
Registration of securities for employees
12:54pm
S-1
EX-10.9
gj8sx5tn20bm2ro
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.14
eair98t9q3
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.15
x5mn 1spqo7g
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.1
b2a5h8sn
19 Jun 20
IPO registration
4:59pm
DRS/A
EX-10.9
385sr
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
8zec00 pjvnr
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
up3yc xkic
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
7ru8h7 79jgsckm
27 May 20
Draft registration statement (amended)
12:00am
DRS
EX-10.1
mbovch5iogn au
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.9
i0dpn4 qe6t9
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.14
dh6 0j4566vu7lfg
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.15
4gvr6
13 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next